from normolipemic and dyslipemic patients were compared independently with the ones from the controls, the differences were statistically significant (by chisquare test, P <0.01 and p <0.05, respectively). No signifi cant differences were found between normolipemic and dyslipemic patients.
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The fact that many of the patients with lower-limb atheromatosis displayed an abnormal ape E phenotype might partly explain their predisposition to the disease. Moreover, we suggest that the study of ape E microheterogeneity is useful, not only for atherosclerotic patients with dyslipemia but also for normolipemic subjects, to detect a possible predisposition to atherosclerosis, that otherwise would have been overlooked.
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(Nova Biomedical, Waltham, MA) and compared precision and accuracy with that of the IL 943#{174} flame photometer (Instrumentation Laboratory, Lexington, MA), sic#{174} (Technicon Instruments, Tarrytown, NY), Nova 4, and Nova 1. The Lytening 1 and the two Nova instruments were operated in the "flame offset" mode.
With the Lytening 1, results appear 15 s after manual presentation of the specimen and are followed by a 10-s rinse cycle; the Nova 1 requires 1 mm, after which it reports results and is ready for the next specimen. The Lytening 1 prints and displays results simultaneously; the Nova 1 does not have a printer. Both instruments report sodium results to one decimal place and potassium results to two places, requiring the analyst to round data, which increases the possibility of transcription error.
Whole-blood specimens (n = 54, with lithium heparin anticoagulant)
were analyzed by the Lytening 1, centrifuged without delay, and re-analyzed as plasma. Mean sodium concentrations were slightly lower in whole-blood specimens, 137.9 (SD 2.0) mmol/L, than in plasma, 138.8 (SD 1.8) mmol/L (p <0.001, paired t-test), but this difference is not clinically significant. Mean potassium concentrations were the same in both sample types: 3.77 (SD 0.40) and 3.76 (SD 0.41) mmol/L, respectively.
Analysis of variance indicated that the mean concentrations of potassium for patients' serum specimens assayed with all five instruments were statistically the same, but mean sodium concentrations differed, as the following tabulation shows. n = 90; for all others, n = 115.
The manufacturers of the Lytening 1 and Nova claim that when these instruments are used in the "flame offset" mode, results are equivalent to those obtained by flame photometry, the reference method for sodium and potassium. However, sodium values with the Nova 1 and Nova 4 were higher than those obtained with flame photometry, but the Lytening 1 results were equivalent to those provided by flame photometry.
The Amdev and Nova instruments are factory calibrated and not adjustable by the user. This limits the laboratory's ability to adjust an instrument such that results from patients' specimens match those from an in-house or an external reference method.
Four months of on-line precision data for assays of sodium and potassium in a lyophilized control material gave the following CVs (no. of assays in parentheses): Lytening 1, 1.03% (157); Nova 1, 0.64% (111); Nova 4, 0.73% (658); sic, 0.91% (3795) for sodium, and 2.79% (220), 0.99% (128), 1.37% (671), and 1.52% (3942), respectively, for potassium. Bartlett's test for homogeneity of variances (1) did not demonstrate a difference among the instruments in precision for sodium, but does for potassium.
The Lytening 1 is accurate, precise, and reliable, and represents an advance for ISE analyzers in terms of miniaturization and speed. 
